CPhI Worldwide in Frankfurt 2022

1-3 November 2022 - Visit us at stand 91F50 , zone ICSE!


Osmopharm SA is a Swiss pharmaceutical contract manufacturer specialized in the development and production of modified release solid oral form drugs. Osmopharm SA is GMP certified by the Swiss health authority Swissmedic, certificate with European validity thanks to the mutual recognition agreement between EU and Switzerland in accordance with quality and good practices defined by PIC/S (Pharmaceutical Inspection Convention/Co-Operation Scheme). With more than 150 formulations developed, the production capacity reaches 36 tons/month of nonsterile products in solid multi-dose form (controlled release granules) and unit dose form (controlled release tablets and capsules). Products: pellets, capsules, tablets in bulk and final packaging.

See you soon in Frankfurt